First Trust Advisors LP boosted its stake in Cantel Medical Corp. (NYSE:CMD) by 6.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,677 shares of the company’s stock after acquiring an additional 739 shares during the quarter. First Trust Advisors LP’s holdings in Cantel Medical were worth $1,100,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new position in shares of Cantel Medical during the 2nd quarter valued at approximately $376,271,000. Vanguard Group Inc. purchased a new position in shares of Cantel Medical during the 2nd quarter valued at approximately $246,860,000. Neuberger Berman Group LLC purchased a new position in shares of Cantel Medical during the 2nd quarter valued at approximately $96,236,000. Dimensional Fund Advisors LP purchased a new position in shares of Cantel Medical during the 2nd quarter valued at approximately $75,756,000. Finally, Wells Fargo & Company MN purchased a new position in shares of Cantel Medical during the 2nd quarter valued at approximately $75,715,000. Hedge funds and other institutional investors own 84.98% of the company’s stock.
In related news, Chairman Charles M. Diker sold 20,500 shares of the firm’s stock in a transaction on Wednesday, October 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,032,575.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Mark N. Diker sold 7,000 shares of the firm’s stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $98.90, for a total value of $692,300.00. The disclosure for this sale can be found here. Insiders have sold 36,368 shares of company stock worth $3,576,028 over the last 90 days. 12.30% of the stock is currently owned by company insiders.
Cantel Medical Corp. (NYSE CMD) opened at $103.38 on Tuesday. Cantel Medical Corp. has a one year low of $69.21 and a one year high of $108.00. The stock has a market capitalization of $4,451.49, a price-to-earnings ratio of 51.19 and a beta of 1.24. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.49 and a current ratio of 2.41.
Cantel Medical (NYSE:CMD) last announced its quarterly earnings data on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. The firm had revenue of $205.50 million for the quarter, compared to analysts’ expectations of $200.32 million. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. analysts predict that Cantel Medical Corp. will post 2.34 EPS for the current fiscal year.
The company also recently disclosed a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be paid a dividend of $0.085 per share. The ex-dividend date is Tuesday, January 16th. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a yield of 0.17%. Cantel Medical’s dividend payout ratio (DPR) is 8.19%.
ILLEGAL ACTIVITY WARNING: “First Trust Advisors LP Has $1.10 Million Holdings in Cantel Medical Corp. (CMD)” was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.com-unik.info/2017/12/05/first-trust-advisors-lp-has-1-10-million-holdings-in-cantel-medical-corp-cmd.html.
Cantel Medical Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
What are top analysts saying about Cantel Medical Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cantel Medical Corp. and related companies.